BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| (2->1)-beta-D-fructofuranan {Inulin} - Prevotella |
📓
Dietary Inulin Regulated Gut Microbiota and Improved Neonatal Health in a Pregnant Sow Model. Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 716723 Pub: 2021 Epub: 2021 Aug 9 Authors Li H , Ma L , Zhang L , Liu N , Li Z , Zhang F , Liu X , Ma X , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Prevotella |
📓
Modulation of Human Gut Microbiota In Vitro by Inulin-Type Fructan from Codonopsis pilosula Roots. Indian journal of microbiology (Indian J Microbiol ) Vol: 64 Issue 2 Pages: 520-528 Pub: 2024 Jun Epub: 2024 Feb 6 Authors Li J , Cao L , Ji J , Shen M , Gao J , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Prevotella |
📓
Inulin alters gut microbiota to alleviate post-stroke depressive-like behavior associated with the IGF-1-mediated MAPK signaling pathway. Brain and behavior (Brain Behav ) Vol: 14 Issue 1 Pages: e3387 Pub: 2024 Jan Epub: Authors Shao R , Tan X , Pan M , Huang J , Huang L , Bi B , Huang X , Wang J , Li X , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Prevotella |
📓
Dietary supplementation with low and high polymerization inulin ameliorates adipose tissue inflammation via the TLR4/NF-?B pathway mediated by gut microbiota disturbance in obese dogs. Research in veterinary science (Res Vet Sci ) Vol: 152 Issue Pages: 624-632 Pub: 2022 Dec 20 Epub: 2022 Oct 3 Authors Lu J , Zhu D , Lu J , Liu J , Wu Z , Liu L , Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Prevotella |
📓
A novel inulin-type fructan from Asparagus cochinchinensis and its beneficial impact on human intestinal microbiota. Carbohydrate polymers (Carbohydr Polym ) Vol: 247 Issue Pages: 116761 Pub: 2020 Nov 1 Epub: 2020 Jul 13 Authors Sun Q , Zhu L , Li Y , Cui Y , Jiang S , Tao N , Chen H , Zhao Z , Xu J , Dong C , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
